Related Experiment Video
Updated: May 28, 2026

Dissecting Cell-Autonomous Function of Fragile X Mental Retardation Protein in an Auditory Circuit by In Ovo Electroporation
Published on: July 6, 2022
Fragile X syndrome: a psychiatric perspective
1FRAXA Research Foundation, Newburyport, MA 01950, USA. mtranfaglia@fraxa.org
Abstract:
Fragile X syndrome (FXS) is associated with a complex but relatively consistent psychiatric phenotype. Recent research has suggested neural substrates for the behavioral abnormalities typically seen in FXS, and enhanced treatment strategies for managing disabling psychiatric comorbidity. While disease-specific, and possibly disease-modifying, therapeutics are being developed for FXS, currently available psychiatric medications can provide significant symptomatic relief of the hyperactivity, anxiety disorders, and affective disturbances often seen in the course of FXS. However, patients with fragile X may be especially susceptible to the psychiatric side effects of these medications, requiring particular care in prescribing. Recent findings concerning disease mechanisms and treatment strategies are reviewed from the perspective of a clinical psychiatrist, in an effort to enhance conventional pharmacotherapy of FXS.
Insights
Fragile X syndrome (FXS) psychiatric symptoms can be managed with current medications, but careful prescribing is needed due to potential side effects. New disease-specific treatments are also in development for FXS.
Area of Science:
- Neuroscience
- Psychiatry
- Genetics
Background:
- Fragile X syndrome (FXS) presents a consistent psychiatric profile.
- Neural substrates for FXS behavioral issues are being identified.
- Effective treatments for psychiatric comorbidities in FXS are crucial.
Purpose of the Study:
- To review recent findings on FXS disease mechanisms and treatment strategies.
- To provide a clinical psychiatrist's perspective on managing FXS psychiatric comorbidities.
- To enhance conventional pharmacotherapy for FXS.
Main Methods:
- Review of recent research on Fragile X syndrome.
- Analysis of neural substrates related to FXS behavioral abnormalities.
- Evaluation of current pharmacotherapy and potential side effects in FXS patients.
Main Results:
- Current psychiatric medications can alleviate hyperactivity, anxiety, and mood disturbances in FXS.
- Patients with FXS may have increased susceptibility to psychiatric medication side effects.
- Disease-specific therapeutics for FXS are under development.
Conclusions:
- Careful pharmacotherapy is essential for managing FXS psychiatric symptoms.
- Understanding disease mechanisms aids in developing targeted FXS treatments.
- Integrating new findings can improve conventional treatment of FXS.
More Related Videos
08:22A Robust Polymerase Chain Reaction-based Assay for Quantifying Cytosine-guanine-guanine Trinucleotide Repeats in Fragile X Mental Retardation-1 Gene
Published on: September 16, 2019
10:58TMS: Using the Theta-Burst Protocol to Explore Mechanism of Plasticity in Individuals with Fragile X Syndrome and Autism
Published on: December 28, 2010
Related Concept Videos
Sex-linked Disorders
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
Psychological and Sociocultural Causes of Schizophrenia